(Q39282857)

10 September 2017

title

Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain (English)

1 reference

10 September 2017

0 references

1 reference

1 reference

1

Albert Dahan

1 reference

10 September 2017

Erik Olofsen

2

1 reference

10 September 2017

Marnix Sigtermans

3

1 reference

10 September 2017

Ingeborg Noppers

4

1 reference

10 September 2017

Marieke Niesters

5

1 reference

10 September 2017

Leon Aarts

6

1 reference

10 September 2017

Martin Bauer

7

1 reference

10 September 2017

Elise Sarton

8

1 reference

10 September 2017

publication date

17 July 2010

1 reference

10 September 2017

published in

European Journal of Pain

1 reference

10 September 2017

volume

15

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

258-267

1 reference

Complex Regional Pain Syndrome: A Review

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Ketamine and chronic pain--going the distance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

The incidence of complex regional pain syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Placebo and naloxone can alter post-surgical pain by separate mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Modeling the norketamine metabolite in children and the implications for analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

A size standard for pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

The development of new analgesics over the past 50 years: a lack of real breakthrough drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Genetic modulation of the pharmacological treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Animal models of pain: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

The involvement of the mu-opioid receptor in ketamine-induced respiratory depression and antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Measuring the predictive performance of computer-controlled infusion pumps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2010.06.016

10.1016/J.EJPAIN.2010.06.016

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference